{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:52:33Z","timestamp":1792439553291,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ijcard.2026.134989","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:38:52Z","timestamp":1792427932000},"page":"134989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Persistent C-reactive protein elevation and heart failure: Risk marker, mediator, or therapeutic target?"],"prefix":"10.1016","volume":"466","author":[{"given":"Panagiotis","family":"Iliakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134989_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehag100","article-title":"2026 ESC Guidelines for the management of heart failure","author":"K\u00f8ber","year":"2026","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134989_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2026.134934","article-title":"Persistent C-reactive protein elevation and incident heart failure in adults at increased cardiovascular risk: a multinational electronic health record study","volume":"464","author":"Busti","year":"2026","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134989_bb0015","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011199","article-title":"Trajectory of C-reactive protein and incident heart failure in black adults: the Jackson heart study","volume":"17","author":"Hamid","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134989_bb0020","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","article-title":"C-Reactive protein and risk of incident heart failure in patients with cardiovascular disease","volume":"82","author":"Burger","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134989_bb0025","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/nu17071250","article-title":"Tracking pathways linking obesity with heart failure","volume":"17","author":"Manta","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.ijcard.2026.134989_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.126.049997","article-title":"Cheng, central adiposity, systemic inflammation, and incident heart failure: a causal mediation analysis from the Jackson heart study","volume":"15","author":"Chen","year":"2026","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2026.134989_bb0035","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with Canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134989_bb0040","series-title":"Novo Nordisk Provides Update on the ZEUS Phase 3 Trial in People with ASCVD, CKD and Inflammation","author":"Novo Nordisk","year":"2026"},{"key":"10.1016\/j.ijcard.2026.134989_bb0045","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ejhf\/xuag153","article-title":"Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials","volume":"28","author":"Mendieta","year":"2026","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134989_bb0050","author":"PACE-CME"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326008399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326008399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:30:01Z","timestamp":1792438201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326008399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":10,"alternative-id":["S0167527326008399"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134989","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent C-reactive protein elevation and heart failure: Risk marker, mediator, or therapeutic target?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134934","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134989"}}